How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Protein Multiplex Assay Market
- By Product Type: Bead-based Multiplex Assays, Planar Array Multiplex Assays, Microfluidic Multiplex Assays, ELISA-based Multiplex Assays
- By Application: Biomarker Discovery, Drug Discovery and Development, Clinical Diagnostics, Proteomics Research, Immunology Studies
- By End User: Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Clinical Diagnostic Laboratories, Contract Research Organizations (CROs), Hospitals and Clinics
- By Detection Technology: Fluorescence Detection, Chemiluminescence Detection, Electrochemiluminescence Detection, Colorimetric Detection
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Bead-based Multiplex Assays leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 277 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.166 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.174 →
Full report · locked preview
Everything inside the Protein Multiplex Assay Market report
A complete, evidence-based study - 11 chapters and 116 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Product Type 4
Application 5
End User 5
Detection Technology 4
Companies profiled
Thermo Fisher Scientific
Bio-Rad Laboratories
Merck KGaA (MilliporeSigma)
Luminex Corporation
Quanterix Corporation
Olink Proteomics
Meso Scale Diagnostics
PerkinElmer
BD Biosciences
Abcam
RayBiotech
ProteinSimple (a Bio-Techne brand)
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Thermo Fisher Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Bio-Rad Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Merck KGaA (MilliporeSigma)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Luminex Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Quanterix Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Olink Proteomics
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Meso Scale Diagnostics
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →PerkinElmer
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →BD Biosciences
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Abcam
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →RayBiotech
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →ProteinSimple (a Bio-Techne brand)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Cytokine Assay & Analysis Services (various CROs)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →R&D Systems (Bio-Techne)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Myriad RBM
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$5,823M by 2033 · 5.0% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Bead-based Multiplex Assays57.7
- Planar Array Multiplex Assays14.4
- Microfluidic Multiplex Assays11.1
- ELISA-based Multiplex Assays16.7
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,298M → $2,013M · 5.6%
Europe$905.0M → $1,198M · 3.6%
Asia Pacific$826.3M → $1,156M · 4.3%
Latin America$511.5M → $851.9M · 6.6%
Middle East and Africa$393.5M → $629.3M · 6.0%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →4.982026
4.982027
5.012028
5.012029
5.032030
5.042031
5.042032
5.062033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Thermo Fisher Scientific21.5
- Bio-Rad Laboratories13.1
- Merck KGaA (MilliporeSigma)6.2
- Luminex Corporation12.6
- Quanterix Corporation9.3
- Olink Proteomics9.2
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type22.3%
Application35.5%
End User17.2%
Detection Technology25.0%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.4
- Europe20.5
- Asia Pacific19.8
- Latin America14.6
- Middle East and Africa10.8
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | 95 | 76 | 85 | 92 | 93 | 75 | 86 |
| Bio-Rad Laboratories | 93 | 74 | 93 | 84 | 88 | 86 | 86 |
| Merck KGaA (MilliporeSigma) | 87 | 86 | 67 | 80 | 77 | 80 | 80 |
| Luminex Corporation | 77 | 80 | 81 | 62 | 75 | 78 | 76 |
| Quanterix Corporation | 59 | 68 | 75 | 53 | 55 | 69 | 63 |
| Olink Proteomics | 68 | 55 | 65 | 46 | 69 | 50 | 59 |
| Meso Scale Diagnostics | 55 | 63 | 50 | 58 | 63 | 62 | 59 |
| PerkinElmer | 50 | 49 | 60 | 43 | 50 | 47 | 50 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Thermo Fisher Scientific
- Bio-Rad Laboratories
- Merck KGaA (MilliporeSigma)
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | ◐ | ✓ | ◐ | ✓ | ✓ | ✓ |
| Bio-Rad Laboratories | ✓ | ✓ | ✓ | ◐ | ✓ | ✓ |
| Merck KGaA (MilliporeSigma) | ◐ | ✓ | ◐ | ✓ | ✓ | ◐ |
| Luminex Corporation | ✓ | ✓ | ◐ | ◐ | ✓ | ◐ |
| Quanterix Corporation | ◐ | − | ✓ | − | − | ✓ |
| Olink Proteomics | ◐ | ◐ | ✓ | ◐ | ◐ | − |
| Meso Scale Diagnostics | ◐ | − | − | ◐ | − | ◐ |
| PerkinElmer | ◐ | ◐ | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Thermo Fisher Scientific86
2Bio-Rad Laboratories86
3Merck KGaA (MilliporeSigma)80
4Luminex Corporation76
5Quanterix Corporation63
6Olink Proteomics59
7Meso Scale Diagnostics59
8PerkinElmer50
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Thermo Fisher ScientificBio-Rad LaboratoriesMerck KGaA (MilliporeSigma)
Challenger1
Strong scale, closing on the leaders.
Luminex Corporation
Contender3
Focused players with pockets of strength.
Quanterix CorporationOlink ProteomicsMeso Scale Diagnostics
Niche1
Specialists in a single segment or region.
PerkinElmer
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across Protein Multiplex Assay Market — a $306M beachhead inside a $4.19B market.
Beachhead (SOM)$306Mobtainable near-term
Serviceable (SAM)$1.75Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion87 fit
Bead-based Multiplex Assays
Best fit — highest urgency & budget in Product Type.
Economic buyer81 fit
Planar Array Multiplex Assays
Strong fit — clear ROI and a fast path to value.
End user70 fit
Microfluidic Multiplex Assays
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel28%
Digital / self-serve20%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Protein Multiplex Assay Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified39%
Sales qualified24%
Evaluation13%
Closed-won6%
$10.2KCAC
$60KLTV
5.9:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Protein Multiplex Assay Market is a high-growth opportunity — $9.57B by 2033, compounding at 10.2%.
TAM · 2025$4.41Btoday
TAM · 2033$9.57Bforecast
CAGR10.2%2027–2033
Cumulative$60.3Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$9.57BTotal addressable market
SAM$3.53BServiceable available market
SOM$641MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →10.2% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$9.57BLarge & growingTAM by 2033 at 10.2% CAGR
$3.53BServiceable nowreachable with today’s model
$641MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$7.47BBear6.6% CAGR
$9.57BBase10.2% CAGR
$12.3BBull13.4% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Protein Multiplex Assay Market — a $7.76B market by 2033. Plan: grow share from 10.3% to 15.9%.
Market size · 2033$7.76Btotal addressable
Market CAGR6.0%2027–2033
Target share15.9%from 10.3% today
Revenue ambition$1.23Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 10.3% | 15.9% | At risk |
| Revenue | $743M | $1.23B | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | Ahead |
| Gross margin | 36.5% | 45.0% | At risk |
| Customer retention | 87.4% | 94.5% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $148M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeBehind
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Protein Multiplex Assay Market conversation — a $3.18B market you can size, segment and defend in minutes.
Market size · 2033$3.18Btotal opportunity
Growth7.8%CAGR to 2033
Addressable buyers1,004+accounts in scope
Typical ROI5.8×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.8×return on cost, year one
< 3 mopayback period
$80K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Thermo Fisher ScientificBio-Rad LaboratoriesMerck KGaA (MilliporeSigma)Luminex CorporationQuanterix CorporationOlink ProteomicsMeso Scale DiagnosticsPerkinElmer+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Protein Multiplex Assay Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Protein Multiplex Assay Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Protein Molecular Weight Standard Market
Market size, share, segmentation and regional forecast.
$849M market · 2025 base year
View reportProtein Microarray Scanner Market
Market size, share, segmentation and regional forecast.
$915M market · 2025 base year
View reportProtein Microarray Chip Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportProtein Mass Spectrometry Service Market
Market size, share, segmentation and regional forecast.
$876M market · 2025 base year
View reportProtein Marker Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportProtein Labeling Technical Service Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportProtein Labeling Kits Market
Market size, share, segmentation and regional forecast.
$788M market · 2025 base year
View reportProtein Labeling and Conjugation Service Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportProtein Inhibitors Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportProtein Immunoprecipitation Kits Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportProtein Identification Service Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportProtein Identification Analysis Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.